ClinVar Miner

Submissions for variant NM_000492.3(CFTR):c.1820_1903del (p.Met607_Gln634del) (rs121908777)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000046486 SCV000696875 pathogenic Cystic fibrosis 2016-03-28 criteria provided, single submitter clinical testing Variant summary: CFTR c.1820_1903del84 is a large deletion of 84 consecutive nucleotides, resulting in an in-frame deletion of 28 amino acids within the regulatory domain of the CFTR protein. Mutation taster predicts this variant to be disease-causing. This variant was found in 9/730390 control chromosomes at a frequency of 0.0000123, which does not significantly exceed the maximal expected frequency of a pathogenic CFTR allele (0.0129603). This variant has been reported in compound heterozyous state, including deltaF508, in multiple CF patients (mostly Hispanic and Spanish) with moderate to severe phenotypes. One clinical laboratory via ClinVar classified this variant as likely pathogenic, without evidence to independently evaluate. Taken together, this variant was classified as a disease variant/pathogenic.
CFTR-France RCV000046486 SCV001169426 pathogenic Cystic fibrosis 2018-01-29 criteria provided, single submitter curation
Myriad Women's Health, Inc. RCV000046486 SCV001193958 likely pathogenic Cystic fibrosis 2019-12-04 criteria provided, single submitter clinical testing NM_000492.3(CFTR):c.1820_1903del84(aka M607_Q643del) is classified as likely pathogenic in the context of cystic fibrosis. Sources cited for classification include the following: PMID 1373934, 15371903, 10875853, 15858154, 21520337, 10777364, 21474639 and 1284539. Classification of NM_000492.3(CFTR):c.1820_1903del84(aka M607_Q643del) is based on the following criteria: This variant has been observed more frequently in patients with clinical diagnoses than in healthy populations. Please note: this variant was assessed in the context of healthy population screening.
OMIM RCV000046486 SCV000027769 pathogenic Cystic fibrosis 1992-05-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.